A patient may be a candidate for GLP-1 weight loss if they have obesity, overweight with weight-related health concerns, insulin resistance, prediabetes, type 2 diabetes risk, high blood pressure, high cholesterol, fatty liver concerns, sleep apnea risk, or repeated difficulty losing and maintaining weight with lifestyle changes alone
& Brennan, M
If pharmaceutical companies or researchers wanted to move this idea forward, it would require showing that leptin is adding a benefit on top of GLP-1s, said Jens Holst, a professor of physiology at the University of Copenhagen
If there is a tiny drop of blood, press lightly with a cotton ball or gauze
Though the company will not be able to produce copycats of Ozempic or Wegovy en masse, CEO Andrew Dudum has announced Hims & Hers will continue to offer access to personalized treatments, creating a niche market for patients who cannot tolerate the usual formulations of semaglutide
Hashash JG, Thompson CC, Wang AY
